explore -WSS

explore

author：entertainment 2025-09-27 16:36:03 - browse：9

Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022 — Photo illustration: STAT; Photo: Adobe

Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

“Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Pregnancy discrimination could be enabled by AI

WSS

Roche acquires Telavant from Roivant, adding experimental IBD treatment

STAT Readout Newsletter: Biotech news today

CMS should re

Why sickle cell disease is getting the first CRISPR treatment

FDA clears Verve to begin U.S. study of gene

Why sickle cell disease is getting the first CRISPR treatment

leisure time

explore

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Health tech investors get more selective as pandemic boom fades

Bright Health sells Medicare Advantage business to Molina

STAT Summit: Ending the crisis of Black deaths in the U.S.

Activists slam private health insurers over coverage restrictions

Roche acquires Telavant from Roivant, adding experimental IBD treatment

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Summit: Ending the crisis of Black deaths in the U.S.

United colonoscopy coverage change 'may cost lives,' doctors say

Chemotherapy shortages won’t get better under Biden’s latest plan

hotspot

Pfizer plans to depart BIO

Patients' immediate access to test results puts radiologists in a bind

Why a market frenzy over new weight loss drugs defies logic

Congenital heart disease patients face new threat of heart failure

FDA needs staff influx to meet gene therapy needs, Marks says

FDA clears Verve to begin U.S. study of gene

entertainment

focus

hotspot

leisure time